share_log

海南葫芦娃药业集团股份有限公司关于收到上海证券交易所《关于终止对海南葫芦娃药业集团股份有限公司向不特定对象发行可转换公司债券审核的决定》的公告

Hainan Huluwa Pharmaceutical Group Co., Ltd. received the Shanghai Stock Exchange\'s “Decision on Termination of the Review of Hainan Huluwa Pharmaceutical Group Co., Ltd.\'s Issuance of Convertible Corporate Bonds to Unspecified Targets”

SZSI ·  Sep 8, 2024 12:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more